From clinical chemistry to digital pathology: Read more about how modern medical laboratories and procedures in pathology play a vital role in the detection and prevention of diseases and in medical research.
Why does the same genetic mutation cause FCDII in some patients but not in others? Researchers developed organoids to model a brain malformation responsible for drug-resistant epilepsy in children.
A multidisciplinary team of pathologists, oncologists and biologists has discovered a new biomarker to determine whether immunotherapy may work in people with colon and rectal cancer.
Tick‑borne encephalitis is one of the most dangerous viral diseases spread in Europe. Researchers have discovered how the viruses replicate inside cells, paving the way for future treatments.
Scientists from the University of Maryland School of Medicine and colleagues create the first-ever immune-capable “Cervix-on-a-chip” to study sexually transmitted infections (STIs).
Researchers have developed an AI model showing that it is possible to detect different neurodegenerative diseases - for example, Alzheimer’s and Lewy body disease - from a single blood sample.
A tick's saliva keeps blood flowing, disarms the immune system, and smuggles in pathogens. Scientists have just found out how to disrupt this process and prevent infection.
Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.
Earlier detection, better outcomes: A new blood test for bowel cancer screening is designed to transform cancer outcomes by moving away from invasive or unpleasant methods.
A biomarker discovered in the cerebrospinal fluid could improve diagnosis of Parkinson's disease and dementia with Lewy bodies.
New treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and motor neurone disease (MND) could be unlocked thanks to microscopic medicines called intrabodies.
Severe infections could increase the risk of developing dementia years later, independently of other coexisting illnesses, a new study from Finland suggests.
A new X-ray imaging technique could transform how hospitals analyse tissue samples, potentially speeding up diagnoses and improving outcomes for patients, a new study shows.
Sakura Finetek and Hamamatsu Photonics K.K. have announced a collaboration aimed at standardising slide preparation and digitisation to support diagnostic accuracy in pathology.
Bacterial infections can be difficult to distinguish from viral infections and inflammation, but a simple breath test may change that. This could reduce unnecessary antibiotic prescriptions.
Scientists have discovered the protective role of a bacterium that could prevent long Covid. Their discovery could lead to the development of new therapy approaches.
Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM Phosphorylated tau 217 (pTau217) and the Atellica IM Brain Derived Tau (BDTau) assays. Both are run on the Atellica Solution IM and Atellica CI Analyzers.
Glioblastoma is notorious for late diagnosis, rapid progression, resistance to treatment and its biological complexity. A new experimental method could help detect this deadly type of brain cancer.
Antibiotics can affect the composition of the community of bacteria living in the gut, known as the gut microbiome, for as long as four to eight years after treatment, a new study shows.
Researchers discovered that pineoblastoma, retinoblastoma and medulloblastoma – severe brain tumours in children that appear to be completely different – actually arise from the same type of cell.
On March 18–19, 2026, Poznań will host the fourth edition of the Laboratory Equipment and Technology Trade Fair, Labs Expo – an event combining presentations of modern technological solutions with an intensive, content-rich conference program. This year’s agenda has been designed for practitioners, including laboratory managers, QC and R&D specialists, metrologists, auditors,…
Coronaviruses can generate new variants capable of infecting humans after circulating in animal reservoirs. Researchers develop broad-spectrum antiviral drugs to curb the spread of these pathogens.
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy, significantly reducing the chances of survival. Researchers found there is more than one way this can happen.
Pancreatic cancer remains a diagnostic challenge, due to unspecific early symptoms and lack of effective screening tools. A novel AI metabolomics platform could help overcome these issues.
“The bacteria effectively hide in a bunker”: New research reveals a surprising mechanism used by Acinetobacter baumannii and Pseudomonas aeruginosa to protect themselves from antibiotics.
Clues in the CSF: Researchers have developed the first high-precision method that can theoretically diagnose common brain tumors in children and adolescents without surgery.
